Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8765813 Use of treprostinil to treat and prevent ischemic lesions

Patent 8765813 was granted and assigned to United Therapeutics on July, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

87658130

Patent Inventor Names

Deborah Strootman0

Michael Wade0

Robert Roscigno0

Roger Jeffs0

Kathryn Bronstein0

Date of Patent

July 1, 2014

Patent Application Number

110127230

Date Filed

December 16, 2004

Patent Citations Received

‌

US Patent 12102610 Treprostinil salt

‌

US Patent 11660304 Dry powder treprostinil for the treatment of pulmonary hypertension

‌

US Patent 11672775 Treprostinil prodrugs

‌

US Patent 11712442 Dry powder treprostinil for the treatment of pulmonary hypertension

‌

US Patent 11744835 Dry powder treprostinil for the treatment of pulmonary hypertension

‌

US Patent 11744836 Dry powder treprostinil for the treatment of pulmonary hypertension

‌

US Patent 11802105 Treprostinil derivatives and compositions and uses thereof

‌

US Patent 11866402 Treprostinil derivatives and compositions and uses thereof

...

Patent Primary Examiner

‌

Raymond Henly, III

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8765813 Use of treprostinil to treat and prevent ischemic lesions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API